A London based pharmaceutical company has searched through research of over sixty various strains of cannabis to identify one that they believe may hold the key to slowing and better managing type-2 diabetes.

GW Pharmaceuticals recently filed a patent for the manufacturing and use of a chemical compound called tetrahydrocannabivarin (THCV) that is found […]